Skip to main content
Premium Trial:

Request an Annual Quote

Netherlands Provides $18M for New Proteomics Facility

NEW YORK (GenomeWeb News) – The Netherlands has pumped €13.5 million ($17.9 million) into a new proteomics research facility that will support research and foster collaboration with partners at several major Dutch life sciences institutes, according to Utrecht University.

Funded by the Netherlands Organization for Scientific Research, the [email protected] facility will provide technologies, equipment, and expertise for proteomics and protein interaction research throughout the country.

The large-scale proteomics facility will consist of a core hub facility at Utrecht University, with smaller labs at the Netherlands Cancer Institute, the Erasmus Medical Centre Rotterdam, and the University Medical Centre in Utrecht.

The facility, which will build upon the resources provided by the Netherlands Proteomics Centre and the Prime-XS proteomics facility, will provide open access to life scientists at universities and hospitals and in industry.

"We work with everybody who wants to understand how proteins work, for example how proteins can cause disease, but also how stem cells can develop into healthy organs," Albert Heck, scientific director of the Netherlands Proteomics Centre and initiator of [email protected], said in a statement.

Concurrent with the funding announcement for the [email protected] facility, the University of Utrecht also said that the Netherlands Organization for Scientific Research has awarded €18.5 million for a nuclear magnetic resonance and MRI imaging facility to study Alzheimer's and Parkinson's diseases and for drug development and agricultural research that will be a partnership between Utrecht University and several other Dutch universities.

The Scan

Should've Been Spotted Sooner

Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier.

For Martian Fuel

Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo.

To Boost Rapid Testing

The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests.

PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing

In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.